Pancreatic Cancer Research

ResearcherUniversity of LiverpoolActive in the last 2 years

Michael C. Schmid

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3445-0013; OpenAlex author ID A5056700264. Sources: OpenAlex.

Their work

Papers
17 (first author 1, last author 7)
Trials
0
Grants
0
Labs led
1
Collaborators
44
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: 5 papers · 2017: none · 2018: 2 papers · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: 5 papers · 2025: 1 paper

Papers 17

  1. Neoadjuvant treatment versus upfront surgery in borderline resectable and resectable pancreatic ductal adenocarcinoma: meta-analysis. Co-author DOI 10.1093/bjsopen/zrae172↗
  2. Expression of versican isoforms V0/V1 by pancreatic cancer associated fibroblasts increases fibroblast proliferation. Co-author DOI 10.1016/j.pan.2024.04.008↗
  3. Macrophage-fibroblast JAK/STAT dependent crosstalk promotes liver metastatic outgrowth in pancreatic cancer. Last author DOI 10.1038/s41467-024-47949-3↗
  4. Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis. Last author DOI 10.1038/s43018-024-00731-2↗
  5. Author Correction: Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis. Last author DOI 10.1038/s43018-024-00751-y↗
  6. Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis. Co-author DOI 10.1158/0008-5472.can-23-1542↗
  7. Chemotherapy-induced infiltration of neutrophils promotes pancreatic cancer metastasis via Gas6/AXL signalling axis. Last author DOI 10.1136/gutjnl-2021-325272↗
  8. Blockade of Stromal Gas6 Alters Cancer Cell Plasticity, Activates NK Cells, and Inhibits Pancreatic Cancer Metastasis. Co-author DOI 10.3389/fimmu.2020.00297↗
  9. MST1R kinase accelerates pancreatic cancer progression via effects on both epithelial cells and macrophages. Co-author DOI 10.1038/s41388-019-0811-9↗
  10. Macrophage-Derived Granulin Drives Resistance to Immune Checkpoint Inhibition in Metastatic Pancreatic Cancer. Last author DOI 10.1158/0008-5472.can-17-3876↗
  11. F1F0-ATP Synthase Inhibitory Factor 1 in the Normal Pancreas and in Pancreatic Ductal Adenocarcinoma: Effects on Bioenergetics, Invasion and Proliferation. Co-author DOI 10.3389/fphys.2018.00833↗
  12. UHRF1 regulation of the Keap1-Nrf2 pathway in pancreatic cancer contributes to oncogenesis. Co-author DOI 10.1002/path.4665↗
  13. Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis. Last author DOI 10.1038/ncb3340↗
  14. Corrigendum: Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis. Last author DOI 10.1038/ncb3377↗
  15. Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors. Co-author DOI 10.1158/0008-5472.can-16-1201↗
  16. Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma Progression. Co-author DOI 10.1158/2159-8290.cd-15-1346↗
  17. Impact of tumour associated macrophages in pancreatic cancer. First author DOI 10.5483/bmbrep.2013.46.3.036↗

Closest collaborators

The 25 strongest of 44 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ainhoa Mielgo Iza · 13 shared papers, 2013–2025 · strength 1.83
  2. Paula Ghaneh · 6 shared papers, 2022–2025 · strength 1.10
  3. Christopher Michael Halloran · 6 shared papers, 2022–2025 · strength 1.10
  4. Meirion Raymant Raymant · 6 shared papers, 2018–2024 · strength 0.99
  5. Valeria Quaranta · 8 shared papers, 2016–2024 · strength 0.85
  6. Gaia Bellomo · 5 shared papers, 2022–2024 · strength 0.84
  7. Daniel H. Palmer · 7 shared papers, 2016–2024 · strength 0.81
  8. Robert Peter Jones · 4 shared papers, 2022–2024 · strength 0.67
  9. Mark A. Glenn · 3 shared papers, 2024 · strength 0.66
  10. Yuliana Astuti · 4 shared papers, 2022–2024 · strength 0.64
  11. Jennifer P. Morton · 4 shared papers, 2022–2024 · strength 0.64
  12. Lucy Ireland · 5 shared papers, 2016–2024 · strength 0.50
  13. Teifion Luckett · 2 shared papers, 2020–2024 · strength 0.36
  14. Carolyn Rainer · 5 shared papers, 2016–2022 · strength 0.34
  15. Sufyan Elhashani · 1 shared paper, 2024 · strength 0.28
  16. Luke Dickerson · 1 shared paper, 2025 · strength 0.26
  17. Daniel H. Palmer · 1 shared paper, 2025 · strength 0.26
  18. Sebastian Rune Nielsen · 4 shared papers, 2016–2018 · strength 0.21
  19. Dannielle D. Engle · 4 shared papers, 2016–2018 · strength 0.21
  20. David Arthur Tuveson · 4 shared papers, 2016–2018 · strength 0.21
  21. Eithne Costello · 2 shared papers, 2016–2018 · strength 0.12
  22. Philippe Foubert · 2 shared papers, 2016–2019 · strength 0.12
  23. Judith A. Varner · 2 shared papers, 2016–2019 · strength 0.12
  24. Andrew M. Lowy · 2 shared papers, 2016–2019 · strength 0.12
  25. Helen Tanton · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.